ORAL IBUPROFEN PREPARATION
PROBLEM TO BE SOLVED: To provide an oral ibuprofen preparation in which the gastric mucosal injury action of ibuprofen is improved at a high level.SOLUTION: The present invention provides an oral ibuprofen preparation containing ibuprofen, magnesium oxide and glycyrrhizinic acid. Preferably, the con...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; jpn |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | PROBLEM TO BE SOLVED: To provide an oral ibuprofen preparation in which the gastric mucosal injury action of ibuprofen is improved at a high level.SOLUTION: The present invention provides an oral ibuprofen preparation containing ibuprofen, magnesium oxide and glycyrrhizinic acid. Preferably, the content of magnesium oxide is 0.01-8.0 pts.wt. relative to ibuprofen 1 pts.wt., and the content of glycyrrhizinic acid is 0.01-0.2 pts.wt. relative to ibuprofen 1 pts.wt.SELECTED DRAWING: Figure 1
【課題】イブプロフェンの有する胃粘膜障害作用を高いレベルで改善した、経口イブプロフェン製剤を提供。【解決手段】イブプロフェン、酸化マグネシウム及びグリチルリチン酸を含有してなる経口イブプロフェン製剤、特に酸化マグネシウムの含有量が、イブプロフェン１重量部に対し０.０１〜８.０重量部、グリチルリチン酸の含有量が、イブプロフェン１重量部に対し０.０１〜０.２重量部である経口イブプロフェン製剤。【選択図】図１ |
|---|